Benjamin Reingold is an associate at Belmore Neidrauer LLP. Ben’s practice focuses on intellectual property litigation involving patents, trademarks, copyright, and trade secrets. Before joining Belmore Neidrauer LLP, Ben practiced as an IP litigation associate with a global law firm.
Ben earned his J.D. from The University of Western Ontario in 2013, where he stood on the Dean’s List and won the Fox Cup as a member of the best team at the 2012 Harold G. Fox Intellectual Property Moot. As well, Ben was a quarterfinalist at the Oxford International IP Moot.
Prior to attending law school, Ben earned a B.Sc.H. degree in biology from York University, graduating in the First Class. Ben also earned a M.Sc. degree in Cell Biology from York University and some of his graduate research was published in the Journal of Endocrinology.
Education
- Called to the Ontario Bar, 2014
- The University of Western Ontario Faculty of Law, J.D., 2013
- York University, M.Sc. (Cell Biology), 2010
- York University, B.Sc. (First Class) (Spec. Hons. Biology), 2008
Awards
IP Stars 2020: Rising Star 2020/21
Cases
| Date |
Case |
Title |
Expertise |
|
Jan 02, 2020 |
2020 FC 1 |
Seedlings Life Sciences v Pfizer
We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’...
|
Patents
|
|
Apr 10, 2018 |
Federal Court File Nos. T-598-17 through T-605-17 |
AbbVie Corporation et al v Samsung Bioepis Co. Ltd.
We represented AbbVie in a series of eight applications under the PMNOC Regulations relating to AbbVie’s blockbuster drug HUMIRA. The c...
|
Patents
|
|
Apr 09, 2018 |
Federal Court File No. T-1355-17 |
Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al.
We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s ...
|
Patents
|
|
Feb 08, 2018 |
2018 FCA 33 |
Teva Canada Limited v. Janssen Inc.
We successfully represented Janssen on Teva’s appeal from an award of damages and costs in respect of Teva’s infringement of the patent...
|
Patents
|
|
Nov 18, 2016 |
2016 ONSC 7151 |
Actavis Pharma Company v Alcon Canada Inc. et al.
We obtained an order dismissing Actavis’ claims for monetary relief under the UK and Ontario Statutes of Monopolies, in an action for damage...
|
Patents
|
More Cases
Affiliations
- Intellectual Property Institute of Canada
- The Advocates’ Society
- Ontario Bar Association
- Toronto Intellectual Property Group
- Law Society of Upper Canada